Wednesday, June 7, 2023

NIAID Funding News, June 7, 2023

NIH/NIAID Template Banner

June 7, 2023 NIAID Funding News

Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news/2023-06-07

Feature Articles 

Successful Sample Applications Demonstrate Good Grantsmanship

To observe how other applicants approach grantsmanship, examine the text sections of our successful example applications—particularly their Specific Aims and Research Plans.

Opportunities and Resources

Have you observed radiation-associated sex differences in your early-stage research to advance animal models, medical countermeasure development, safety, or biomarker science?

Conduct mechanistic studies of early-stage tuberculosis (TB) infection in the airway and lungs with and without HIV to identify interventional targets for vaccine and host-directed therapies.

Each center will create and provide access to interactive knowlegebases, innovative tools and software, and leading-edge expertise in bioinformatics.

In The News

NIH received more than 800 responses to a request for information on simplifying peer review criteria, a vast majority of which supported most of the proposed changes.

NIH tasks peer reviewers with identifying the most promising trainees as well as excellent, individualized training programs that will help them become outstanding scientists.

NIH's Office of Research on Women's Health offers training modules, videos, and other tools to instruct biomedical researchers on properly accounting for sex as a biological variable.

Advice Corner

NIH grant recipients have 120 days from the end of a performance period to liquidate obligations by drawing funds from the Payment Management System.

Reader Questions

New Funding Opportunities

  • PAR-23-203, Limited Competition—Collaborative Partnership to Advance Global Health Research (U01, Clinical Trial Not Allowed)
  • PAR-23-198, NIAID New Innovators Awards (DP2, Clinical Trial Not Allowed)
  • PAR-23-206, NIAID Clinical Trial Planning Grant (R34, Clinical Trial Not Allowed)
  • BAA-NIAID-75N93023R00002, Innovations in Functional B Cell Epitope Discovery

Find other announcements at NIAID Opportunities & Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

No comments:

Post a Comment

Private investors pour $50 billion into booming sector… investment opportunity

Unstoppable megatrend driven by hundreds of billions in government spending ...